Home
>
National Drug Code (NDC)
>
ENTACAPONE
ENTACAPONE - 47335-203-83 - (ENTACAPONE)
Drug Information of ENTACAPONE
| Product NDC: | 47335-203 |
| Proprietary Name: | ENTACAPONE |
| Non Proprietary Name: | ENTACAPONE |
| Active Ingredient(s): | 200 mg/1 & nbsp; ENTACAPONE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ENTACAPONE
| Product NDC: | 47335-203 |
| Labeler Name: | Sun Pharma Global FZE |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090690 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120718 |
Package Information of ENTACAPONE
| Package NDC: | 47335-203-83 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (47335-203-83) |
NDC Information of ENTACAPONE
| NDC Code | 47335-203-83 |
| Proprietary Name | ENTACAPONE |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (47335-203-83) |
| Product NDC | 47335-203 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ENTACAPONE |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120718 |
| Marketing Category Name | ANDA |
| Labeler Name | Sun Pharma Global FZE |
| Substance Name | ENTACAPONE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC] |
